Pharmacologic properties of venlafaxine.
作者信息
Smith M N
出版信息
J Clin Psychiatry. 1997 Apr;58(4):178-9. doi: 10.4088/jcp.v58n0407h.
PMID:9164435
Abstract
摘要
相似文献
1
Pharmacologic properties of venlafaxine.文拉法辛的药理特性。
J Clin Psychiatry. 1997 Apr;58(4):178-9. doi: 10.4088/jcp.v58n0407h.
2
Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.血清素去甲肾上腺素再摄取抑制剂在儿科注意力缺陷多动障碍治疗中的应用。
Ann Pharmacother. 2014 Jan;48(1):86-92. doi: 10.1177/1060028013506561. Epub 2013 Oct 9.
3
[Serotonin-noradrenaline reuptake inhibitors(SNRIs)].[5-羟色胺-去甲肾上腺素再摄取抑制剂（SNRIs）]
Nihon Rinsho. 2001 Aug;59(8):1523-9.
4
Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.血清素、去甲肾上腺素和多巴胺再摄取抑制剂联合给药对大鼠前额叶皮质中血清素和多巴胺水平的相互作用：5-HT1A受体的作用
J Psychopharmacol. 2007 Nov;21(8):795-804. doi: 10.1177/0269881107077347.
5
Venlafaxine for adult ADHD.
Am J Psychiatry. 1995 Jul;152(7):1099-100. doi: 10.1176/ajp.152.7.1099b.
6
Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.生物学视角。5-羟色胺和去甲肾上腺素再摄取抑制剂（SNRIs）：文拉法辛和度洛西汀。
Perspect Psychiatr Care. 2006 May;42(2):144-8. doi: 10.1111/j.1744-6163.2006.00064.x.
7
Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.5-羟色胺、去甲肾上腺素和多巴胺再摄取抑制剂对仓鼠昼夜活动节律中光诱导的相位提前的影响评估。
Psychopharmacology (Berl). 2007 Dec;195(3):325-32. doi: 10.1007/s00213-007-0903-z. Epub 2007 Aug 13.
8
Effects of venlafaxine treatment for ADHD in a child.
Am J Psychiatry. 1995 Jul;152(7):1099. doi: 10.1176/ajp.152.7.1099a.
9
Combination treatment with venlafaxine and bupropion.文拉法辛和安非他酮联合治疗。
Am J Psychiatry. 1999 Mar;156(3):494. doi: 10.1176/ajp.156.3.494.
10
Venlafaxine in obsessive-compulsive disorder.文拉法辛治疗强迫症
Arch Gen Psychiatry. 1996 Jul;53(7):653-4. doi: 10.1001/archpsyc.1996.01830070103016.
Zotero 插件